Cortex Pharmaceuticals Inc.: The Irvine drug development...
- Share via
Cortex Pharmaceuticals Inc.: The Irvine drug development company posted a loss of $1.5 million, or 5 cents a share, for its first fiscal quarter, which ended Sept. 30. That compared to a loss of $875,805, or 5 cents share, for the same period a year earlier. The company reported no revenue.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
